Paper32633366
LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539.
Wang HX and 4 others. Eur Rev Med Pharmacol Sci, 2020. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539. Papers, record 32633366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32633366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Cell Proliferation | Major topic |
| Lung Neoplasms | Major topic |
| MicroRNAs | Major topic |
| RNA, Long Noncoding | Major topic |
| A549 Cells | |
| Humans |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41186719 | Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41186719 | PubMed |
| 38850527 | Construction and validation of a prognostic signature based on anoikis-related lncRNAs in lung adenocarcinoma. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38850527 | PubMed |
| 37559586 | Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib. | Oncol Lett | 2023 | https://conductscience.org/library/papers/37559586 | PubMed |
| 37529164 | LINC00460 mediates HMGA2 expression through binding to miRNA-143-5p competitively in gastric carcinoma. | Turk J Biol | 2023 | https://conductscience.org/library/papers/37529164 | PubMed |
| 37251440 | Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy. | Oxid Med Cell Longev | 2023 | https://conductscience.org/library/papers/37251440 | PubMed |
| 36938678 | LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis. | Technol Cancer Res Treat | 2023 | https://conductscience.org/library/papers/36938678 | PubMed |
| 35083132 | Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/35083132 | PubMed |
| 35076836 | CTBP1-AS2 promoted non-small cell lung cancer progression via sponging the miR-623/MMP3 axis. | Environ Sci Pollut Res Int | 2022 | https://conductscience.org/library/papers/35076836 | PubMed |
| 34831421 | Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer. | Cells | 2021 | https://conductscience.org/library/papers/34831421 | PubMed |
| 34821482 | LncRNA LINC00460: Function and mechanism in human cancer. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/34821482 | PubMed |
| 34601499 | miR-539 activates the SAPK/JNK signaling pathway to promote ferropotosis in colorectal cancer by directly targeting TIPE. | Cell Death Discov | 2021 | https://conductscience.org/library/papers/34601499 | PubMed |
| 34429655 | Aberration of lncRNA LINC00460 is a Promising Prognosis Factor and Associated with Progression of Clear Cell Renal Cell Carcinoma. | Cancer Manag Res | 2021 | https://conductscience.org/library/papers/34429655 | PubMed |
| 34367998 | The Impact of lncRNAs and miRNAs on Apoptosis in Lung Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34367998 | PubMed |
| 34275932 | Significance of LINC00460 in the progression and prognosis in digestive tract tumors. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2021 | https://conductscience.org/library/papers/34275932 | PubMed |
| 33912452 | LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related Genes. | Front Oncol | 2021 | https://conductscience.org/library/papers/33912452 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LINC00460 | 728192 | PubTator's text mining | https://conductscience.org/library/genes/728192 | NCBI Gene |
| MIR539 | 664612 | PubTator's text mining | https://conductscience.org/library/genes/664612 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32633366
GET https://conductscience.org/api/papers/v1/32633366/authors